The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

Nature Neuroscience

Volumn 4, Issue 9, 2001, Pages 887-893

  Nilsberth, Camilla ^a   Westlind Danielsson, Anita ^a,b   Eckman, Christopher B ^c   Condron, Margaret M ^d   Axelman, Karin ^a   Forsell, Charlotte ^a   Stenh, Charlotte ^a   Luthman, Johan ^b   Teplow, David B ^d   Younkin, Steven G ^c   Näslund, Jan ^a   Lannfelt, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c MAYO CLINIC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CELL PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; CELL LINE; CULTURE MEDIA; HETEROZYGOTE; HUMANS; MIDDLE AGED; MUTATION; PEDIGREE; PEPTIDE FRAGMENTS; SWEDEN;

EID: 17944368176     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn0901-887     Document Type: Article

References (40)

1. Amyloid, the presenilins and Alzheimer's disease
2. Translating cell biology into therapeutic advances in Alzheimer's disease
3. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid
4. Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation
5. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation
6. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
7. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type
8. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene
9. Flemish and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion
10. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor
11. 693→ Gln 'Dutch' mutation on the production and stability of amyloid β-protein
12. Amyloid β-protein fibrillogenesis - Detection of protofibrillar intermediate
13. 692→Gly) Alzheimer's disease
14. A new βPP mutation related to hereditary cerebral haemorrhage
15. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy
16. Interaction between Aβ(1-42) and Aβ(1-40) in Alzheimer's β-amyloid fibril formation in vitro
17. Structural and kinetic features of amyloid β-protein fibrillogenesis
18. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-β protein
19. Observation of metastable Aβ amyloid protofibrils by atomic force microscopy
20. 1-42 are potent central nervous system neurotoxins
21. Amyloid β-protein fibrillogenesis - Structure and biological activity of protofibrillar intermediates
22. Assembly of Aβ amyloid protofibrils: An in vitro model for a possible early event in Alzheimer's disease
23. Protofibrillar intermediates of amyloid β-protein induce acute eletrophysiological changes and progressive neurotoxicity in cortical neurons
24. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
25. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region
26. 717) mutants
27. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
28. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
29. Amyloid β protein in plasma from patients with sporadic Alzheimer's disease
30. Amyloid β protein in plasma as a diagnostic marker for Alzheimer's disease
31. Plasma amyloid β-peptide 1-42 and incipient Alzheimer's disease
32. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
33. The Aβ 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater β-sheet forming and aggregation propensities in vitro than full-length Aβ
34. Arrest of β-amyloid fibril formation by a pentapeptide ligand
35. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation
36. Intracellular APP processing and Aβ production in Alzheimer disease
37. Intraneuronal Aβ42 accumulation in human brain
38. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truth and physiological consequences of the time-dependent solubility of amyloid proteins
39. Targeting small Aβ oligomers: The solution to an Alzheimer's disease conundrum?
40. Amyloid precursor protein mutation at codon 713 (Ala→Val) does not cause schizophrenia: Non-pathogenic variant found at codon 705 (silent)